The Latest: Pfizer looks at vaccine with fewest side effects
NEW YORK - Pfizer and its German partner BioNTech will take its COVID-19 vaccine candidate with the fewest side effects into final-stage testing. |!| Elko
NEW YORK - Pfizer and its German partner BioNTech will take its COVID-19 vaccine candidate with the fewest side effects into final-stage testing. |!| Elko